Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Clinical trial NCT05359653 · RECRUITING

Trial details

NCT number: NCT05359653
Sponsor: University of California, San Francisco
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis (MS)Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Chronic Progressive Multiple Sclerosis Relapse Multiple Sclerosis Brain Lesion Multiple Sclerosis Benign

Start date: 2023-08-01
Primary completion: 2027-06-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.